title: Correlation of DNA ploidy with progression of cervical cancer.
abstract: The majority of squamous cell carcinomas of cervix are preceded by visible changes in the cervix, most often detected by cervical smear. As cervical cancer is preceded by long precancerous stages, identification of the high-risk population through detection of DNA ploidy may be of importance in effective management of this disease. Here we attempted to correlate aneuploid DNA patterns and their influence on biological behavior of flow-cytometry analysis of DNA ploidy which was carried out in cytologically diagnosed cases of mild (79), moderate (36), and severe (12) dysplasia, as well as "atypical squamous cells of unknown significance (ASCUS)" (57) along with controls (69), in order to understand its importance in malignant progression of disease. Cytologically diagnosed dysplasias, which were employed for DNA ploidy studies, 39 mild, 28 moderate, and 11 severe dysplasia cases were found to be aneuploid. Out of the 69 control subjects, 6 cases showed aneuploidy pattern and the rest 63 subjects were diploid. An aneuploidy pattern was observed in 8 out of 57 cases of cytologically evaluated ASCUS. The results of the followup studies showed that aberrant DNA content reliably predicts the occurrence of squamous cell carcinoma in cervical smear. Flow cytometric analysis of DNA ploidy may provide a strategic diagnostic tool for early detection of carcinoma cervix. Therefore, it is a concept of an HPV screening with reflex cytology in combination with DNA flow cytometry to detect progressive lesions with the greatest possible sensitivity and specificity.
authors.affiliation: Industrial Toxicology Research Center, P.O. Box 80, M.G. Marg, Lucknow 226001, India.
authors.forename: M
authors.initials: M
authors.lastname: Singh
authors.forename: S
authors.initials: S
authors.lastname: Mehrotra
authors.forename: N
authors.initials: N
authors.lastname: Kalra
authors.forename: U
authors.initials: U
authors.lastname: Singh
authors.forename: Y
authors.initials: Y
authors.lastname: Shukla
references.citation: Cell Oncol. 2004;26(3):143-50
references.pmid: 15371650
references.citation: Clin J Oncol Nurs. 2006 Aug;10(4):527-31
references.pmid: 16927906
references.citation: Eur J Gynaecol Oncol. 2003;24(1):13-7
references.pmid: 12691309
references.citation: Contemp Clin Trials. 2006 Oct;27(5):449-71
references.pmid: 16765101
references.citation: N Engl J Med. 2001 Apr 26;344(17):1270-8
references.pmid: 11320386
references.citation: Anal Quant Cytol Histol. 2002 Feb;24(1):23-9
references.pmid: 11865946
references.citation: Diagn Cytopathol. 2006 Aug;34(8):528-41
references.pmid: 16850481
references.citation: Anal Cell Pathol. 1998;17(4):201-8
references.pmid: 10391372
references.citation: Cancer. 2004 Jun 25;102(3):192-9
references.pmid: 15211479
references.citation: Anal Cell Pathol. 2001;23(2):89-95
references.pmid: 11904464
references.citation: Cancer. 2004 Feb 25;102(1):41-54
references.pmid: 14968417
references.citation: Clin Cancer Res. 2004 May 1;10(9):3059-63
references.pmid: 15131043
references.citation: Cancer. 2001 Jun 25;93(3):222-8
references.pmid: 11391611
references.citation: Am J Obstet Gynecol. 1999 Sep;181(3):560-6
references.pmid: 10486464
references.citation: JAMA. 2000 Jan 5;283(1):87-93
references.pmid: 10632285
references.citation: J Immunol Methods. 1991 Jun 3;139(2):271-9
references.pmid: 1710634
references.citation: Acta Cytol. 2001 Jul-Aug;45(4):499-501
references.pmid: 11480708
references.citation: Cancer Detect Prev. 1997;21(3):242-6
references.pmid: 9167041
references.citation: Curr Opin Oncol. 2000 Jan;12(1):82-8
references.pmid: 10687734
references.citation: Neoplasma. 1990;37(5):497-500
references.pmid: 2234211
references.citation: JAMA. 2000 May 17;283(19):2525-6
references.pmid: 10815111
references.citation: J Natl Cancer Inst. 2001 Jan 17;93(2):92-4
references.pmid: 11208877
references.citation: Int J Gynecol Pathol. 1993 Jul;12(3):193-207
references.pmid: 7688352
references.citation: Cell Cycle. 2004 Jun;3(6):823-8
references.pmid: 15197343
references.citation: Int J Cancer. 1993 Jun 19;54(4):594-606
references.pmid: 8514451
references.citation: J Clin Pathol. 1993 Aug;46(8):700-2
references.pmid: 8408692
references.citation: Virology. 1991 Sep;184(1):9-13
references.pmid: 1651607
references.citation: Cytometry. 2001 Jun 15;46(3):166-71
references.pmid: 11449407
references.citation: Methods Cell Biol. 1994;41:263-96
references.pmid: 7861967
references.citation: Biochim Biophys Acta. 1996 Oct 9;1288(2):F55-78
references.pmid: 8876633
references.citation: Diagn Cytopathol. 2001 Mar;24(3):153-6
references.pmid: 11241896
references.citation: Anal Cell Pathol. 1995 Jan;8(1):67-74
references.pmid: 7734413
references.citation: Cancer. 2003 Apr 25;99(2):113-7
references.pmid: 12704691
references.citation: Pathologe. 1999 Jan;20(1):25-33
references.pmid: 10091229
references.citation: JAMA. 2002 Apr 24;287(16):2114-9
references.pmid: 11966386
references.citation: Anal Quant Cytol Histol. 1990 Oct;12(5):306-13
references.pmid: 2176502
references.citation: J Clin Microbiol. 2003 Feb;41(2):608-12
references.pmid: 12574254
references.citation: Cancer Lett. 1998 Jan 16;123(1):47-52
references.pmid: 9461017